The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...

Cancer remains a leading cause of death globally, with breast cancer being the most fatal for women. A recent American Cancer ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

Inside Edition' reporter Alison Hall undergoes a double mastectomy, after discovering her breast cancer while on assignment.

"Based on data from the eight eligible studies from 2019 to 2023, the committee concludes that compared with never consuming ...

The $30 million facility was made possible, in part, through a $4 million contribution through the AdventHealth Palm Coast ...

A new report shows that cancer cases are increasing in females in the United States and in younger adults. For the first time ...

As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for ...